The fall magazines are always fat with ads, and the latest issues of People were no exception. I was happy to spot many DTC ads in one very hefty issue, two of which really stood out—one for Pfizer’s ...
Will AbbVie back off Humira advertising now that it’s announced it will buy Allergan? Maybe. But for now, the Illinois drugmaker is showing no signs of slowing its long-running robust TV ad push for ...
More than one-fourth of all top-10 pharma TV spending in July came from one brand—AbbVie's Humira. The immunology blockbuster brand dropped $42.5 million on TV ads, well ahead of Gilead Sciences’ ...
Image above from a recent Humira ad. The Humira wars have begun, as the first branded biosimilar to break Abbvie’s 20-year exclusivity on the top-selling anti-inflammatory drug has launched, cutting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback